A carregar...
Breast Cancer Outcomes of Neoadjuvant vs Adjuvant Chemotherapy by Receptor Subtype: a Scoping Review
INTRODUCTION: Trials demonstrate equivalent survival for breast cancers treated with neoadjuvant (NAC) or adjuvant chemotherapy (AC). However, these were conducted prior to the recognition of the importance of receptor subtype for survival and chemotherapy response. Therefore, chemotherapy timing ma...
Na minha lista:
| Publicado no: | J Surg Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7483718/ https://ncbi.nlm.nih.gov/pubmed/32422430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jss.2020.04.011 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|